13 Years after Oxytocin Order, HC Seeks Compilance Status

GWALIOR: The Gwalior Bench of the Madhya Pradesh High Court has directed the state government to submit a comprehensive compliance status report. This order addresses the implementation of the court’s 13-year-old directives aimed at curbing the illegal sale and rampant misuse of the hormone oxytocin.

High Court Demands Status Report

Hearing a contempt petition alleging administrative failure to enforce the restrictions, a single-judge bench of Justice Amit Seth ordered the government advocate to seek immediate instructions from the state.

The Order: The court ordered that a copy of the contempt petition be served to the government advocate within three working days.
Timeline: The state government must submit its official status report detailing active field compliance within four weeks, after which the court will resume hearings.

The 2013 Landmark Judgment

The current legal intervention stems from a landmark Public Interest Litigation (PIL) judgment passed on September 6, 2013. The original petition, moved by advocate V.P. Singh (Vijay Pratap Singh Rajawat), had raised serious alarm over public health hazards linked to the unregulated distribution of hormonal injections.

In its 2013 verdict, the High Court issued clear mandates to regulate the hormone:

Prescription Only: Oxytocin can strictly be purchased only via a prescription issued by a registered medical practitioner or a licensed veterinary doctor.
Agricultural Ban: The hormone cannot be used to artificially enlarge the size or weight of vegetables and fruits (such as bottle gourds, watermelons, and pumpkins).
Poultry Restrictions: The administration of oxytocin to induce rapid, unnatural growth in chickens and poultry farm chicks remains completely prohibited.

Allegations of Enforcement Failure

According to the petitioner’s counsel, Advocate Awadhesh Singh Tomar, the state machinery has failed to restrict open-market availability. The plea notes that local vendors and commercial farms continue to exploit the drug. This open exploitation circumvents the Food Safety and Standards Act guidelines, despite previous notices served to top state officials, including the Principal Secretary of Health.

During the primary proceedings, the Union Government clarified that while macro-policies exist, the ground-level enforcement of these food safety bans falls entirely on individual state administrations.

Related Posts

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

The Drugs Control Administration (DCA) of Himachal Pradesh achieved a major milestone by securing an appreciation award from the Pharmaceuticals Export Promotion Council of India (Pharmexcil), operating under the ministry…

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

The Drugs Licensing Authority (DLA), Baddi, has cancelled the manufacturing licence, product licences and permissions of M/s Sharika Biotech at Jagatkhana village in Nalagarh after around 1,200 kg of unauthorised…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation

4 arrested in Nashik for illegally procuring prescription drugs online & selling to gym-goers

4 arrested in Nashik for illegally procuring prescription drugs online & selling to gym-goers

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research